Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma-Reference-Cited by-同舟云学术

Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma

Published:2021-11-09 Issue:11 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Vaarwerk Bas¹²,Breunis Willemijn B²³,Haveman Lianne M¹²,de Keizer Bart¹,Jehanno Nina⁴,Borgwardt Lise⁵,van Rijn Rick R⁶,van den Berg Henk²,Cohen Jérémie F⁷⁸,van Dalen Elvira C¹,Merks Johannes HM¹²

Affiliation:

1. Princess Máxima Center for Pediatric Oncology; Utrecht Netherlands

2. Department of Paediatric Oncology; Emma Children's Hospital, Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands

3. Department of Oncology and Children's Research Center; University Children's Hospital Zurich; Zurich Switzerland

4. Department of Nuclear Medicine; Institut Curie; Paris France

5. Department of Clinical Physiology, Nuclear Medicine and PET; Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark

6. Department of Radiology and Nuclear Medicine; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands

7. Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé); Centre of Research in Epidemiology and Statistics (CRESS), UMR1153, Université de Paris; Paris France

8. Department of General Pediatrics and Pediatric Infectious Diseases; Necker - Enfants malades hospital, Assistance Publique - Hôpitaux de Paris, Paris Descartes University; Paris France

Publisher

Wiley

Subject

Pharmacology (medical)

Reference96 articles.

1. 18F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas;Eugene;Nuclear Medicine Communications,2012

2. Additional benefit of F-18 FDG PET/CT in the staging and follow-up of pediatric rhabdomyosarcoma;Ricard;Clinical Nuclear Medicine,2011

3. Semi-quantitative calculations of primary tumor metabolic activity using F-18 FDG PET/CT as a predictor of survival in 92 patients with high-grade bone or soft tissue sarcoma;Andersen;Medicine (Baltimore),2015

4. Diagnostic and clinical impact of 18F-FDG PET/CT in staging and restaging soft-tissue sarcomas of the extremities and trunk: mono-Institutional retrospective study of a sarcoma referral center;Annovazzi;Journal of Clinical Medicine,2020

5. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma;Arush;Pediatric Blood & Cancer,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic adaptations in prostate cancer;British Journal of Cancer;2024-07-05

2. A bibliometric analysis based on hotspots and frontier trends of positron emission tomography/computed tomography utility in bone and soft tissue sarcoma;Frontiers in Oncology;2024-06-21

3. Computational Techniques in PET/CT Image Processing for Breast Cancer: A Systematic Mapping Review;ACM Computing Surveys;2024-04-26

4. Bone marrow disease in rhabdomyosarcoma visualized by 2-[18F]fluorodeoxyglucose positron emission tomography/computed tomography;Pediatric Radiology;2024-04-26

5. Automated extraction of the arterial input function from brain images for parametric PET studies;EJNMMI Research;2024-04-01